Premaitha Health (LON:NIPT)‘s stock had its “corporate” rating reaffirmed by analysts at FinnCap in a report issued on Wednesday.

Shares of NIPT opened at GBX 12.65 ($0.16) on Wednesday. Premaitha Health has a 1 year low of GBX 4.05 ($0.05) and a 1 year high of GBX 12.50 ($0.16).

Premaitha Health Company Profile

Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.

Read More: Outstanding Shares, Buying and Selling Stocks

Receive News & Ratings for Premaitha Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premaitha Health and related companies with MarketBeat.com's FREE daily email newsletter.